Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Branch of National Clinical Research Center for Laboratory Medicine, Nanjing, Jiangsu, China.
Clin Cardiol. 2022 Jun;45(6):664-669. doi: 10.1002/clc.23829. Epub 2022 Apr 11.
Infective endocarditis (IE) has a significant mortality, and early identification of high-risk patients and prediction of poor outcomes is of great significance. In recent years, increasing research has revealed the predictors associated with infective endocarditis prognosis. Systemic inflammatory response index (SIRI) is an important new indicator of inflammation. So far, there have been no reports on the relationship between SIRI and the prognosis of IE patients.
The purpose of this study was to explore the value of SIRI in predicting in-hospital death for patients with infective endocarditis (IE), so as to provide reference for improving the prognosis of patients with IE.
A retrospective analysis was performed on the clinical data of patients with IE admitted to the First Affiliated Hospital of Nanjing Medical University from January 2017 to December 2019. SIRI was calculated according to the blood routine results of patients at admission; receiver operating characteristic curve was employed to determined the optimal cutoff value of SIRI. Patients were divided into groups (low SIRI group and high SIRI group; nonsurvivor group and survivor group) according to the levels of SIRI or their prognosis, and the general clinical features of the two groups were compared. Univariate and multivariate logistic regression analysis were performed to analyze the independent prognostic factors of in-hospital death in IE patients.
A total of 147 IE patients meeting the diagnostic criteria were included, including 102 males (69.4%) and 45 females (30.6%). There was statistically significant difference in SIRI level between nonsurvivor group and survivor group (p < .05). After adjusting for the related factors, the risk of in-hospital death in the high SIRI was still a risk of in-hospital death with statistical significance (hazard ratio = 5.053, 95% confidence interval: 1.426-17.905, p = .012).
Higher SIRI level is independently associated with the risk of in-hospital death in IE patients, and can be an independent predictor of poor outcome in IE patients.
感染性心内膜炎(IE)死亡率较高,早期识别高危患者和预测不良预后具有重要意义。近年来,越来越多的研究揭示了与感染性心内膜炎预后相关的预测因素。全身炎症反应指数(SIRI)是炎症的一个重要新指标。目前,尚无关于 SIRI 与 IE 患者预后关系的报道。
本研究旨在探讨 SIRI 预测感染性心内膜炎(IE)患者住院期间死亡的价值,为改善 IE 患者预后提供参考。
回顾性分析 2017 年 1 月至 2019 年 12 月南京医科大学第一附属医院收治的 IE 患者的临床资料。根据患者入院时的血常规结果计算 SIRI;采用受试者工作特征曲线确定 SIRI 的最佳截断值。根据 SIRI 水平或预后将患者分为低 SIRI 组和高 SIRI 组(非幸存者组和幸存者组),比较两组的一般临床特征。采用单因素和多因素 logistic 回归分析 IE 患者住院期间死亡的独立预后因素。
共纳入符合诊断标准的 147 例 IE 患者,其中男 102 例(69.4%),女 45 例(30.6%)。非幸存者组和幸存者组 SIRI 水平差异有统计学意义(p < .05)。在校正相关因素后,高 SIRI 组住院期间死亡的风险仍具有统计学意义(危险比=5.053,95%置信区间:1.426-17.905,p = .012)。
较高的 SIRI 水平与 IE 患者住院期间死亡风险独立相关,可作为 IE 患者不良预后的独立预测指标。